Asthma Allergy Immunology

Asthma Allergy Immunology

2017, Vol 15, Num, 3     (Pages: 162-164)

Tenoxicam-Induced Fixed Drug Eruption Confirmed by Skin Patch Test

İnsu Yılmaz , Nuri Tutar 2, Sevim Yenigün 2, Zuhal Özer Şimşek 2, İnci Gülmez 2,

1 Erciyes Üniversitesi Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, İmmünoloji ve Allerji Hastalıkları Bilim Dalı, Kayseri, Türkiye
2 Erciyes Üniversitesi Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, Kayseri, Türkiye

DOI: 10.21911/aai.76
Viewed: 712
Downloaded : 357

Fixed drug eruption (FDE) with oxicams is very rare. FDE due to tenoxicam has been reported in several case reports. Skin patch test with the suspected or responsible drug is applied on sites of previous lesions developing with FDE. Recently, the test has been used quite often for diagnosis of FDE although results are variable. Our case was a 63-year-old woman who had developed itching and erythematous lesions 3-5 cm in size localized on her hands and elbows 3-4 hours after the intake of tenoxicam and ranitidine. The lesion became vesiculobullous a few days later. After two weeks, it resolved with hyperpigmentation. The diagnosis of tenoxicaminduced FDE was confirmed after applying patch and provocation tests. Here we described a case of bullous fixed drug eruption due to tenoxicam and we demonstrated the contribution of skin patch tests to the FDE diagnosis.

Keywords : Tenoxicam, fixed drug eruption, skin patch test